Giovanni Barosi
Unit of Clinical Epidemiology and Center for the Study of Myelofibrosis
IRCCS Policlinico S. Matteo Foundation
Viale Golgi 19
27100 Pavia
Italy
Name/email consistency: high
- Emerging targeted therapies in myelofibrosis. Barosi, G. Expert. Rev. Hematol (2012)
- SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma. Barosi, G., Merlini, G., Billio, A., Boccadoro, M., Corradini, P., Marchetti, M., Massaia, M., Tosi, P., Palumbo, A., Cavo, M., Tura, S. Ann. Hematol. (2012)
- Management of myeloproliferative neoplasms: from academic guidelines to clinical practice. Barosi, G., Lupo, L., Rosti, V. Curr. Hematol. Malig. Rep (2012)
- Therapeutic approaches in myelofibrosis. Barosi, G., Rosti, V., Vannucchi, A.M. Expert. Opin. Pharmacother (2011)
- Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference. Barosi, G., Birgegard, G., Finazzi, G., Griesshammer, M., Harrison, C., Hasselbalch, H.C., Kiladjian, J.J., Lengfelder, E., McMullin, M.F., Passamonti, F., Reilly, J.T., Vannucchi, A.M., Barbui, T. Blood (2009)
- Novel strategies for patients with chronic myeloproliferative disorders. Barosi, G., Rosti, V. Curr. Opin. Hematol. (2009)
- New consensus: a unified definition of clinical resistance and/or intolerance to hydroxyurea in essential thrombocythaemia. Barosi, G. Eur. J. Haematol. Suppl (2007)
- JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis. Barosi, G., Bergamaschi, G., Marchetti, M., Vannucchi, A.M., Guglielmelli, P., Antonioli, E., Massa, M., Rosti, V., Campanelli, R., Villani, L., Viarengo, G., Gattoni, E., Gerli, G., Specchia, G., Tinelli, C., Rambaldi, A., Barbui, T. Blood (2007)
- A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group. Barosi, G., Besses, C., Birgegard, G., Briere, J., Cervantes, F., Finazzi, G., Gisslinger, H., Griesshammer, M., Gugliotta, L., Harrison, C., Hasselbalch, H., Lengfelder, E., Reilly, J.T., Michiels, J.J., Barbui, T. Leukemia (2007)
- Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. Barosi, G., Carella, A., Lazzarino, M., Marchetti, M., Martelli, M., Rambaldi, A., Tarella, C., Vitolo, U., Zinzani, P.L., Tura, S. Haematologica (2006)
- Allogeneic hematopoietic stem cell transplantation for myelofibrosis. Barosi, G., Bacigalupo, A. Curr. Opin. Hematol. (2006)
- Strategies for dissemination and implementation of guidelines. Barosi, G. Neurol. Sci. (2006)
- Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET). Barosi, G., Bordessoule, D., Briere, J., Cervantes, F., Demory, J.L., Dupriez, B., Gisslinger, H., Griesshammer, M., Hasselbalch, H., Kusec, R., Le Bousse-Kerdiles, M.C., Liberato, N.L., Marchetti, M., Reilly, J.T., Thiele, J. Blood (2005)
- Management of nodal indolent (non marginal-zone) non-Hodgkin's lymphomas: practice guidelines from the Italian Society of Hematology, Italian Society of Experimental Hematology and Italian Group for Bone Marrow Transplantation. Barosi, G., Carella, A., Lazzarino, M., Marchetti, M., Martelli, M., Rambaldi, A., Tarella, C., Vitolo, U., Zinzani, P.L., Tura, S. Haematologica (2005)
- Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasia. Barosi, G., Rosti, V., Massa, M., Viarengo, G.L., Pecci, A., Necchi, V., Ramaioli, I., Campanelli, R., Marchetti, M., Bazzan, M., Magrini, U. Br. J. Haematol. (2004)
- Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO). Barosi, G., Boccadoro, M., Cavo, M., Corradini, P., Marchetti, M., Massaia, M., Merlini, G., Tosi, P., Tura, S. Haematologica (2004)
- Myelofibrosis with myeloid metaplasia. Barosi, G. Hematol. Oncol. Clin. North Am. (2003)
- High prevalence of a screening-detected, HFE-unrelated, mild idiopathic iron overload in Northern Italy. Barosi, G., Salvaneschi, L., Grasso, M., Martinetti, M., Marchetti, M., Bodini, U., Reggiani, A., D'Agostino, F., Nalli, G., Degiuli, A., De Silvestri, A., Arbustini, E. Haematologica (2002)
- Thalidomide in myelofibrosis with myeloid metaplasia: a pooled-analysis of individual patient data from five studies. Barosi, G., Giovanni, B., Elliott, M., Michelle, E., Canepa, L., Letizia, C., Ballerini, F., Filippo, B., Piccaluga, P.P., Pier Paolo, P., Visani, G., Giuseppe, V., Marchetti, M., Monia, M., Pozzato, G., Gabriele, P., Zorat, F., Francesca, Z., Tefferi, A., Ayalew, T. Leuk. Lymphoma (2002)
- Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia. Barosi, G., Grossi, A., Comotti, B., Musto, P., Gamba, G., Marchetti, M. Br. J. Haematol. (2001)
- Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia. Barosi, G., Viarengo, G., Pecci, A., Rosti, V., Piaggio, G., Marchetti, M., Frassoni, F. Blood (2001)
- The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia. Barosi, G., Ambrosetti, A., Finelli, C., Grossi, A., Leoni, P., Liberato, N.L., Petti, M.C., Pogliani, E., Ricetti, M., Rupoli, S., Visani, G., Tura, S. Br. J. Haematol. (1999)
- Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines. Barosi, G. J. Clin. Oncol. (1999)